MOHW starts substitute Olita for patients’ convenience
The Ministry of Health and Welfare(MOHW) decided to focus more on other drug substitutes over Olita whose development is terminated.
The MOHW expressed a stance about reviewing plans to terminate the development of Hanmi Pharm’s Olita Tab 200mg & 400mg on the 13th.
Hanmi Pharm turned in the pla...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.